Kushi Institute, a Macrobiotic non-profit study center located in Becket, MA, in conjunction with University of California at Riverside, and Hippocrates Institute, is seeking three participants for a pilot clinical study on Caloric Restricted diet, (CR), to affect particular gene expression in cancer.
Participants must meet the following requirements:
• Diagnosis of melanoma or breast cancer with residual skin lesions of disease
• Either received any type of conventional treatment unsuccessfully, or are newly diagnosed and currently untreated
• Interested in electing nutritional intervention as their only present treatment of their cancer
• Active with good performance measurements, able to eat, walk, and travel
Researchers will study participant’s gene expression before and after a six month period. Participants will undergo a skin biopsy of their lesion and have a blood sample collected twice during the study.
During this six month period of study, participants will follow an individualized Macrobiotic diet plan, designed for them by Kushi Institute counselors for their specific condition.
In the initial two week study period, participants will reside at Kushi Institute campus in the beautiful Berkshire Hills, living, eating, and attending educational programs. This insures that each participant will confidently know how to follow their particular diet and how to prepare counselor’s specific recommendations at home.
To assure compliance to the diet, Kushi Institute research staff will monitor each candidate on a weekly basis. Staff will also check for any adverse reactions and make recommendations.
Participation is voluntary and one may discontinue from the study at anytime. This study does not include medical drugs of any kind.
For more information on the study, or to apply to be considered a participant, please call Olaf Fischer at 413-623-5741 x 160 or email olaf@kushiinstitute.org with the subject heading, “CR study.”
Catherine on 7/4/2012 at 9:37 am said:
Woah – that was a little bit troubling to see the different size tumours. To think that was once inside, it’s kind of hard to accept. Simply bizarre.
Assisted Living Directory on 7/9/2012 at 10:05 pm said:
Really bizarre indeed. The top tumor size is frightening. The visual really puts quite a perspective on it.
Olaf Fischer on 8/2/2012 at 10:12 am said:
Looking for people to participate in Cancer Study
Kushi Institute, a Macrobiotic non-profit study center located in Becket, MA, in conjunction with University of California at Riverside, and Hippocrates Institute, is seeking three participants for a pilot clinical study on Caloric Restricted diet, (CR), to affect particular gene expression in cancer.
Participants must meet the following requirements:
• Diagnosis of melanoma or breast cancer with residual skin lesions of disease
• Either received any type of conventional treatment unsuccessfully, or are newly diagnosed and currently untreated
• Interested in electing nutritional intervention as their only present treatment of their cancer
• Active with good performance measurements, able to eat, walk, and travel
Researchers will study participant’s gene expression before and after a six month period. Participants will undergo a skin biopsy of their lesion and have a blood sample collected twice during the study.
During this six month period of study, participants will follow an individualized Macrobiotic diet plan, designed for them by Kushi Institute counselors for their specific condition.
In the initial two week study period, participants will reside at Kushi Institute campus in the beautiful Berkshire Hills, living, eating, and attending educational programs. This insures that each participant will confidently know how to follow their particular diet and how to prepare counselor’s specific recommendations at home.
To assure compliance to the diet, Kushi Institute research staff will monitor each candidate on a weekly basis. Staff will also check for any adverse reactions and make recommendations.
Participation is voluntary and one may discontinue from the study at anytime. This study does not include medical drugs of any kind.
For more information on the study, or to apply to be considered a participant, please call Olaf Fischer at 413-623-5741 x 160 or email olaf@kushiinstitute.org with the subject heading, “CR study.”